TEMPORAL RESPONSE PATTERNS OF ABROCITINIB AND DUPILUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF THE JADE DARE TRIAL

被引：0
|
作者：
Trzeciak, Magdalena [1 ]
Chovatiya, Raj [2 ]
Geng, Bob [3 ]
Biswas, Pinaki [4 ]
Guler, Erman [5 ]
机构：
[1] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland
[2] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL USA
[3] Univ Calif San Diego, Dept Dermatol, Sch Med, San Diego, CA USA
[4] Pfizer Inc, New York, NY USA
[5] Pfizer Inc, Istanbul, Turkiye
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P4.6
引用
收藏
页码：30 / 31
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
    Eric L. Simpson
    Jonathan I. Silverberg
    Jacob P. Thyssen
    Manuelle Viguier
    Diamant Thaçi
    Marjolein de Bruin-Weller
    Stephan Weidinger
    Gary Chan
    Marco DiBonaventura
    Pinaki Biswas
    Claire Feeney
    Christopher Koulias
    Michael J. Cork
    American Journal of Clinical Dermatology, 2023, 24 : 609 - 621
  • [42] Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis The JADE TEEN Randomized Clinical Trial
    Eichenfield, Lawrence F.
    Flohr, Carsten
    Sidbury, Robert
    Siegfried, Elaine
    Szalai, Zsuzsanna
    Galus, Ryszard
    Yao, Zhirong
    Takahashi, Hidetoshi
    Barbarot, Sebastien
    Feeney, Claire
    Zhang, Fan
    DiBonaventura, Marco
    Rojo, Ricardo
    Valdez, Hernan
    Chan, Gary
    JAMA DERMATOLOGY, 2021, 157 (10) : 1165 - 1173
  • [43] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
    Beck, Lisa A.
    Thaci, Diamant
    Hamilton, Jennifer D.
    Graham, Neil M.
    Bieber, Thomas
    Rocklin, Ross
    Ming, Jeffrey E.
    Ren, Haobo
    Kao, Richard
    Simpson, Eric
    Ardeleanu, Marius
    Weinstein, Steven P.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    Suarez-Farinas, Mayte
    Hager, Melissa D.
    Stahl, Neil
    Yancopoulos, George D.
    Radin, Allen R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 130 - 139
  • [44] Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Thyssen, Jacob P.
    Viguier, Manuelle
    Thaci, Diamant
    de Bruin-Weller, Marjolein
    Weidinger, Stephan
    Chan, Gary
    DiBonaventura, Marco
    Biswas, Pinaki
    Feeney, Claire
    Koulias, Christopher
    Cork, Michael J.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (04) : 609 - 621
  • [45] Dupilumab offers rapid improvement in pruritus in adolescents with moderate-to-severe atopic dermatitis vs placebo: a post hoc analysis of a phase III trial
    Simpson, E. L.
    Gadkari, A.
    Beck, L. A.
    Hong, H. C. H.
    Bansal, A.
    Chen, Z.
    Mina-Osorio, P.
    Prescilla, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E94 - E95
  • [46] Abrocitinib in the treatment of moderate-to-severe atopic dermatitis refractory to dupilumab treatment: an analysis of JADE-EXTEND (a phase III long-term extension study)
    Shi, V.
    Bhutani, T.
    Deleuran, M.
    Fonacier, L.
    Shumack, S.
    Zhang, F.
    Cameron, M. C.
    Chan, G.
    Valdez, H.
    Yin, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E138 - E138
  • [47] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
    Schmid-Grendelmeier, Peter
    Gooderham, Melinda J.
    Hartmann, Karin
    Konstantinou, George N.
    Fellmann, Marc
    Koulias, Christopher
    Clibborn, Claire
    Biswas, Pinaki
    Brunner, Patrick M.
    ALLERGY, 2024, 79 (01) : 174 - 183
  • [48] Abrocitinib in the treatment of moderate-to-severe atopic dermatitis refractory to dupilumab treatment: An analysis of JADE-EXTEND, a phase 3 long-term extension study
    Shi, Vivian
    Bhutani, Tina
    Deleuran, Mette
    Fonacier, Luz
    Shumack, Stephen
    Zhang, Fan
    Cameron, Michael C.
    Chan, Gary
    Valdez, Hernan
    Yin, Natalie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB36 - AB36
  • [49] Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate-to-Severe Atopic Dermatitis
    Paller, Amy S.
    Eichenfield, Lawrence F.
    Irvine, Alan D.
    Flohr, Carsten
    Wollenberg, Andreas
    Barbarot, Sebastien
    Bangert, Christine
    Spergel, Jonathan M.
    Selfridge, Andrew
    Biswas, Pinaki
    Fan, Haiyun
    Alderfer, Justine
    Watkins, Melissa
    Koppensteiner, Herwig
    ALLERGY, 2025,
  • [50] THE IMPACT OF BASELINE DISEASE SEVERITY ON SHORT-TERM EFFICACY OF ABROCITINIB AND DUPILUMAB IN PATIENTS WITH ATOPIC DERMATITIS: A POST HOC ANALYSIS OF THE PHASE 3 JADE COMPARE TRIAL
    Rice, Zakiya P.
    Gooderham, Melinda J.
    Lebwohl, Mark G.
    Simpson, Eric L.
    Boguniewicz, Mark
    Wollenberg, Andreas
    Biswas, Pinaki
    Chan, Gary L.
    Alderfer, Justine
    Watkins, Melissa
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 22 - 22
12345